tiprankstipranks
Advertisement
Advertisement
GeneDx price target lowered to $70 from $100 at Guggenheim
PremiumThe FlyGeneDx price target lowered to $70 from $100 at Guggenheim
1M ago
GeneDx price target lowered to $75 from $100 at Canaccord
Premium
The Fly
GeneDx price target lowered to $75 from $100 at Canaccord
1M ago
GeneDx price target lowered to $75 from $155 at Wells Fargo
Premium
The Fly
GeneDx price target lowered to $75 from $155 at Wells Fargo
1M ago
GeneDx sees Q2 revenue $110M-$112M, consensus $128.2M
PremiumThe FlyGeneDx sees Q2 revenue $110M-$112M, consensus $128.2M
1M ago
WGS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
WGS Upcoming Earnings Report: What to Expect?
1M ago
GeneDx management to meet with Craig-Hallum
Premium
The Fly
GeneDx management to meet with Craig-Hallum
1M ago
GeneDx data could support improved coverage, says Craig-Hallum
PremiumThe FlyGeneDx data could support improved coverage, says Craig-Hallum
3M ago
Natera announces commercial launch of Zenith genomics
Premium
The Fly
Natera announces commercial launch of Zenith genomics
3M ago
GeneDx falls after Natera launches sequencing assay for rare diseases
Premium
The Fly
GeneDx falls after Natera launches sequencing assay for rare diseases
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100